Literature DB >> 14377279

The control of deviant behavior in chronically disturbed psychotic patients by the oral administration of reserpine.

B C CAMPDEN-MAIN, Z WEGIELSKI.   

Abstract

Entities:  

Keywords:  PSYCHOSES/psychology; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 14377279     DOI： 10.1111/j.1749-6632.1955.tb42458.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  The current status of the tranquillizing drugs.

Authors:  P L KURTZ
Journal:  Can Med Assoc J       Date:  1958-02-01       Impact factor: 8.262

2.  A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia.

Authors:  M SHEPHERD; D C WATT
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-08       Impact factor: 10.154

3.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

4.  [The Rauwolfia alkaloid, reserpine (serpasil) in psychiatry].

Authors:  F A MIELKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1956

Review 5.  Glutamate and dopamine in schizophrenia: an update for the 21st century.

Authors:  Oliver Howes; Rob McCutcheon; James Stone
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

Review 6.  Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.

Authors:  Paulina Cieślik; Joanna M Wierońska
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.